197 related articles for article (PubMed ID: 2064470)
1. Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.
Tilney NL; Chang A; Milford EL; Whitley WD; Lazarus JM; Ramos EL; Strom TB; Carpenter CB; Kirkman RL
Ann Surg; 1991 Jul; 214(1):42-9. PubMed ID: 2064470
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
Martin DC; Tertzakian G; Ruzics E
J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
[TBL] [Abstract][Full Text] [Related]
3. The effect of cyclosporine on early graft function in human renal transplantation.
Flechner SM; Payne WD; Van Buren C; Kerman R; Kahan BD
Transplantation; 1983 Sep; 36(3):268-72. PubMed ID: 6351368
[TBL] [Abstract][Full Text] [Related]
4. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for second renal allografts immunosuppressed with cyclosporine.
Almond PS; Matas AJ; Gillingham K; Troppmann C; Payne W; Dunn D; Sutherland D; Najarian JS
Transplantation; 1991 Aug; 52(2):253-8. PubMed ID: 1871798
[TBL] [Abstract][Full Text] [Related]
6. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial.
Lancet; 1982 Jul; 2(8289):57-60. PubMed ID: 6123806
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
Schulak JA; Mayes JT; Moritz CE; Hricik DE
Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
[TBL] [Abstract][Full Text] [Related]
9. Experience with cyclosporine and steroids in clinical renal transplantation.
Tilney NL; Milford EL; Araujo JL; Strom TB; Carpenter CB; Kirkman RL
Ann Surg; 1984 Nov; 200(5):605-13. PubMed ID: 6385881
[TBL] [Abstract][Full Text] [Related]
10. Causes of graft loss beyond two years in the cyclosporine era.
Dunn J; Golden D; Van Buren CT; Lewis RM; Lawen J; Kahan BD
Transplantation; 1990 Feb; 49(2):349-53. PubMed ID: 2305464
[TBL] [Abstract][Full Text] [Related]
11. Conversion from cyclosporine to azathioprine in renal allograft recipients.
Rocher LL; Milford EL; Kirkman RL; Carpenter CB; Strom TB; Tilney NL
Transplantation; 1984 Dec; 38(6):669-74. PubMed ID: 6390830
[TBL] [Abstract][Full Text] [Related]
12. Use of cyclosporine in pediatric renal transplant recipients.
Conley SB; Flechner SM; Rose G; Van Buren CT; Brewer E; Kahan BD
J Pediatr; 1985 Jan; 106(1):45-9. PubMed ID: 3880820
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
[No Abstract] [Full Text] [Related]
14. Renal graft survival in children with early acute rejection.
Muñoz R; Romero B; Medeiros M; Zaragoza L
Pediatr Transplant; 1998 Nov; 2(4):294-8. PubMed ID: 10084732
[TBL] [Abstract][Full Text] [Related]
15. Living-unrelated renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
Al-Uzri A; Sullivan EK; Fine RN; Harmon WE
Pediatr Transplant; 1998 May; 2(2):139-44. PubMed ID: 10082446
[TBL] [Abstract][Full Text] [Related]
16. Kidney transplantation in the cyclosporine era.
Halasz NA; Gamboa EA; Ward DM; Steiner RW; Bronsther OL
Arch Surg; 1987 Sep; 122(9):1001-4. PubMed ID: 3304197
[TBL] [Abstract][Full Text] [Related]
17. Renal transplantation in children with emphasis on young patients.
Laine J; Holmberg C; Salmela K; Jalanko H; Sairanen H; Peltola K; Rönnholm K; Eklund B; Wikström S; Leijala M
Pediatr Nephrol; 1994 Jun; 8(3):313-9. PubMed ID: 7917857
[TBL] [Abstract][Full Text] [Related]
18. The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction.
Delmonico FL; Auchincloss H; Rubin RH; Russell PS; Tolkoff-Rubin N; Fang LT; Cosimi AB
Ann Surg; 1987 Nov; 206(5):649-54. PubMed ID: 3314751
[TBL] [Abstract][Full Text] [Related]
19. Highly sensitized patients with delayed graft function: a management protocol.
Hickey DP; Vivas CA; Jordan ML; Lopatin WB; Hrebinko R; O'Donovan R; Hakala TR
J Urol; 1991 Jan; 145(1):131-4. PubMed ID: 1984070
[TBL] [Abstract][Full Text] [Related]
20. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
Sumpio BE; Dwyer JM; Flye MW
Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
